Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

Five magnificent income stocks -- sporting an average yield of 4.26% -- can pad investors' pocketbooks in the new year (and well beyond).

Canadians have another $7,000 in Tax-Free Savings Account (TFSA) contribution space in 2025. One popular TFSA investing ...

These four mega-cap dividend stocks offer the best total return potential for 2025. They are rated Buy at top Wall Street ...

In comparison, according to data from Sentio Capital, global property, as measured by the S&P Global Property Index, achieved ...

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...

We recently published a list of 12 Highest Dividend Stocks to Buy on Cash App. In this article, we are going to take a look ...

SA Quant identifies high-quality, income-generating stocks that can help offset losses for volatile markets and provide ...

Technology has seamlessly woven itself into our daily lives in today’s digital era, significantly impacting how we manage ...

Aflac, Grainger, Target, IBM, Johnson & Johnson, Emerson, Archer-Daniels, McDonald’s and T. Rowe Price rounded out the ...

Realty Income (NYSE: O) has been a reliable dividend stock for long-term investors. It's one of the world's largest real ...